Sorcha Daly
Biographic Data
| ID | 9638205 |
|---|---|
| NAME | Sorcha Daly |
| GIVEN NAMES | Sorcha |
| FAMILY NAME | Daly |
| SIGNATURE | DALY S |
| AFFILIATIONS | University College London |
| ORCID | 0009-0006-9261-6057 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2026 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Contact tracing for hepatitis C
INTRODUCTION: Chronic hepatitis C (HCV) is a major cause of cirrhosis and hepatocellular carcinoma. In the UK, the principal risk factor for HCV is injecting drug use. The introduction of direct acting anti-virals (DAA's) have transformed HCV care, with cure rates of over 95%. However, HCV is often asymptomatic, and reinfection is a concern. Modelling and real-life studies demonstrate the potential effectiveness of a contact tracing approach for …
No prominent works on this page.
Contact tracing for hepatitis C
INTRODUCTION: Chronic hepatitis C (HCV) is a major cause of cirrhosis and hepatocellular carcinoma. In the UK, the principal risk factor for HCV is injecting drug use. The introduction of direct acting anti-virals (DAA's) have transformed HCV care, with cure rates of over 95%. However, HCV is often asymptomatic, and reinfection is a concern. Modelling and real-life studies demonstrate the potential effectiveness of a contact tracing approach for …
Contact tracing (1 work) · Diabetes Management and Education (1 work) · Harm reduction (1 work) · Hepatitis C (1 work) · Hepatitis C virus research (1 work) · HIV, Drug Use, Sexual Risk (1 work) · Injection drug use (1 work) · Qualitative research (1 work) · Tracing (1 work)